Eagle Health Investments’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,000
| Closed | -$236K | – | 30 |
|
|
2023
Q1 | $236K | Hold |
5,000
| – | – | 0.05% | 27 |
|
|
2022
Q4 | $347K | Hold |
5,000
| – | – | 0.08% | 26 |
|
|
2022
Q3 | $733K | Hold |
5,000
| – | – | 0.17% | 26 |
|
|
2022
Q2 | $652K | Hold |
5,000
| – | – | 0.15% | 26 |
|
|
2022
Q1 | $505K | Hold |
5,000
| – | – | 0.12% | 28 |
|
|
2021
Q4 | $774K | Hold |
5,000
| – | – | 0.19% | 27 |
|
|
2021
Q3 | $1.48M | Hold |
5,000
| – | – | 0.47% | 26 |
|
|
2021
Q2 | $1.62M | Buy |
+5,000
| New | +$1.62M | 0.56% | 27 |
|